1492 Capital Management LLC / KURA
1492 Capital Management LLC’s Kura Oncology Inc Position
Does 1492 Capital Management LLC own Kura Oncology Inc (KURA)? Yes — 486.1K shares worth $4M (+1.50% of its 13F portfolio) as of Q1 2026, up from 452.6K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
486.1K
% of Portfolio
+1.50%
Quarters Held
16
currently held
Position History KURA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 486.1K | $4M | +1.50% |
| Q4 2025 | 452.6K | $5M | +1.80% |
| Q3 2025 | 445.6K | $4M | +1.60% |
| Q2 2025 | 423.9K | $2M | +1.13% |
| Q1 2025 | 429.7K | $3M | +1.53% |
| Q4 2024 | 342.6K | $3M | +1.42% |
| Q3 2024 | 73.2K | $1M | +0.71% |
| Q2 2024 | 72.7K | $1M | +0.85% |
| Q1 2024 | 72.9K | $2M | +0.87% |
| Q4 2023 | 101.5K | $1M | +0.83% |
| Q3 2023 | 100.5K | $916,250 | +0.59% |
| Q2 2023 | 100.5K | $1M | +0.62% |
| Q1 2023 | 100.5K | $1M | +0.76% |
| Q4 2022 | 100.5K | $1M | +0.80% |
| Q3 2022 | 40.2K | $549,000 | +0.40% |
| Q2 2022 | 40.2K | $736,000 | +0.48% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 1492 Capital Management LLC’s full portfolio or all institutional holders of KURA.